
Feb 3 (Reuters) - Merck & Co Inc MRK.N:
MERCK OUTLOOK 2026 ADJUSTED EPS $5.00 - $5.15 VERSUS IBES ESTIMATE $5.36
MERCK Q4 ADJUSTED EPS $2.04 VERSUS IBES ESTIMATE $2.01
MERCK OUTLOOK 2026 SALES $65.5 BILLION- $67.0 BILLION VERSUS IBES ESTIMATE $67.60 BILLION
MERCK: 2026 OUTLOOK REFLECTS ONE-TIME CHARGE OF ABOUT $3.65 PER SHARE FOR ACQUISITION OF CIDARA
MERCK Q4 WORLDWIDE SALES $16.40 BILLION VERSUS IBES ESTIMATE $16.19 BILLION
MERCK Q4 WORLDWIDE KEYTRUDA SALES $8.37 BILLION